About this trial
The purpose of this research is to evaluate the safety, feasibility, and tolerability of non-invasive spinal stimulation used in the home and/or community in combination with a functional home exercise program for the upper extremities (arm/hand function) as well as their combined impacts on changes in upper extremity function. The expected duration of participation in this study is about 31-33 hours over a 13-25-week period. Enrollees in this study will be randomly assigned to one of two groups: 1) upper extremity functional task-specific training combined with non-invasive transcutaneous spinal stimulation, or 2) waitlist control, which involves the same intervention, but with a 12-week delayed start. Participants complete initial testing (one time if in group one and three times \[at weeks 0, 8, and 12\] if in group two), 24 1-hour training sessions (2x/week in home with caregiver/companion support and 1x/week with research team in person or via video conference for 8 weeks), a post-treatment evaluation, and a final evaluation (4 weeks after post-treatment).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18 or older
History of traumatic SCI
Less than 12 months post SCI
SCI injury level C1-C8
Disqualifiers
Experience unstable chronic cardiac or respiratory complaints
Have a recent history of fracture, contractures, or skin pressure injuries that might interfere with the intervention
Received Botox injections to the UEs, neck, or hands within the last three months
Pregnant, planning to become pregnant, or currently breastfeeding
Trial design
Parallel
Treatments tested in this trial
Immediate Intervention
BehavioralParticipants will engage in a home exercise therapy program in combination with transcutaneous spinal stimulation intended to focus on the upper extremities that commences immediately after enrollment.
Waitlist control
BehavioralParticipants will engage in a home exercise therapy program in combination with transcutaneous spinal stimulation intended to focus on the upper extremities that commences 12 weeks after enrollment.
Treatment groups
Trial outcomes
Primary outcomes
Capabilities of Upper Extremity Questionnaire (CUE-Q)
The CUE-Q version 2.1 measures functional limitation and perceived difficulty of performing actions with upper extremities in individuals with tetraplegia. The CUE-Q has 32 items; each scored on a 1-to-7-point scale representing self-perceived difficulty with total scores ranging from 32 to 224 (higher scores demonstrating greater UE function) and right and left scores assessed separately
Secondary outcomes
Graded Refined Assessment of Strength, Sensibility, and Prehension (GRASSP)
This multimodal test measures sensorimotor and prehension function in three domains important in describing arm and hand function
International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
The ISNCSCI is a universal classification tool for SCI based on a standardized sensory and motor exam. The ISNCSCI involves a detailed examination to determine the sensory and motor levels for both the right and left sides, the overall neurological level of the injury, and the completeness of the injury as designated by the American Spinal Cord Injury Association (ASIA) Impairment Scale (AIS). The motor exam also results in a total Upper Extremity Motor Score (UEMS) ranging from 0 to 50, with higher scores indicative of greater UE strength.
Pinch and Grasp Force
Pinch and grasp force will be measured by the Commander Echo Console with the JTech Pinch and Hand Dynamometer to quantify finger and grasp strength.
Global Rating of Change (GRC)
The GRC assesses perceived change from an intervention. The scale is designed to quantify an individual's perceived improvement or deterioration over time. The magnitude of the change is then scored on a visual analog scale. GRC scales have been recommended for use as a core outcome measure in rehabilitation studies to improve the applicability of information from clinical trials to clinical practice.
Other outcomes
Demographic Information
Demographic information will include: age, sex, race/ethnic background, pre-injury education, employment status, marital status, and living situation.
Injury Characteristics
Injury information will include: date of injury, cause of injury, baseline AIS classification, and injury level.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Craig Hospital
Lead sponsor
National Institute on Disability, Independent Living, and Rehabilitation Research
Collaborator